Teladoc Health (TDOC) Institutional Ownership

76.82% of Teladoc Health's stock is owned by institutional investors. Learn more on TDOC's institutional investor holdings.

Of the 249 institutional investors that purchased Teladoc Health's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Point72 Asset Management L.P. ($5.88M), Monaco Asset Management SAM ($4.71M), Jupiter Asset Management Ltd. ($3.86M), Maple Rock Capital Partners Inc. ($3.56M), Vanguard Group Inc. ($3.21M), Nuveen LLC ($2.22M), and Trexquant Investment LP ($2.22M).

Institutional investors have bought a total of 30,201,262 shares in the last 24 months. This purchase volume represents approximately $220.30M in transactions.

Of the 56 institutional investors that sold Teladoc Health's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Pale Fire Capital SE ($1.42M), Dimensional Fund Advisors LP ($1.20M), Woodline Partners LP ($1.09M), Two Sigma Investments LP ($1.05M), Vanguard Group Inc. ($427.24K), Robeco Institutional Asset Management B.V. ($416.22K), and Moore Capital Management LP ($379.13K).

Institutional investors have sold a total of 8,677,570 shares in the last 24 months. This volume of shares sold represents approximately $64.10M in transactions.